Know Cancer

or
forgot password
  • cancer clinical trials in chicago, IL

  • An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
    University of Chicago
    Chicago, Illinois 60637
    Mesothelioma
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Chicago, Illinois 60674
    Non Small Cell Lung Cancer
    Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    John H. Stroger, Jr. Hospital of Cook County
    Hematology & Oncology Associates of Illinois
    Multiple Myeloma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Illinois Masonic Medical Center

    Trial Locations
    Illinois Masonic Medical Center
    Swedish Covenant Hospital
    Hematology and Oncology Associates
    Saint Joseph Hospital
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Jesse Brown Veterans Affairs Medical Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    University of Chicago
    Chicago, Illinois 60637
    Thyroid Cancer
    Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Non Small Cell Lung Cancer
    Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
    University of Chicago
    Chicago, Illinois 60637
    Advanced Cancer
    Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Esophageal Cancer
    Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Northwestern University School of Medicine
    Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Childrens Memorial Hospital

    Trial Locations
    Childrens Memorial Hospital
    University of Illinois
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Chicago Comprehensive Cancer Center
    Recurrent Endometrial Carcinoma
    Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
    The University of Chicago Medical Center
    Chicago, Illinois 60637-1470
    Multiple Myeloma
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Colorectal Cancer
    Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Hereditary Clear Cell Renal Cell Carcinoma, Kidney Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Chicago Comprehensive Cancer Center
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    University of Chicago Medical Center
    Chicago, Illinois 60637
    Primary Progressive Multiple Sclerosis
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    Childrens Memorial Hospital
    University of Illinois
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Chicago, Illinois 60614
    Sickle Cell Disease
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    Northwestern University

    Trial Locations
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    Ovarian Stromal Cancer
    Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
    Childrens Memorial
    Chicago, Illinois 60614
    Graft vs Host Disease, Graft-Versus-Host Disease
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Chicago, Illinois 60674
    Non-small Cell Lung Cancer
    Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer
    University of Illinois Cancer Center
    Chicago, Illinois 60612-7243
    Prostate Cancer
    A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy
    John H Stroger Jr Hospital of Cook County
    Chicago, Illinois 60612-3785
    Hand and Foot Syndrome
    CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
    University of Chicago Medical Center
    Chicago, Illinois 60637
    Glioblastoma Multiforme
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Melanoma
    Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
    Cancer and Leukemia Group B
    Chicago, Illinois 60606
    HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Lung Cancer, Non Small Cell Lung Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    Childrens Memorial Hospital
    University of Illinois
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific